Evidence map›Paper›PMID 36816380›Full record

ArticleFrontiers in pediatrics2023

The surge of RSV and other respiratory viruses among children during the second COVID-19 pandemic winter season.

Angela Riepl, Lena Straßmayr, Peter Voitl, Paulina Ehlmaier, Julian J M Voitl, Klara Langer, Ulrike Kuzio, Alexandra Mühl-Riegler, Bernhard Mühl, Susanne C Diesner-Treiber

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Beyond respiratory syncytial virus and rhinovirus: The other viral respiratory bandits.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2025
    Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Angela RieplFirst Vienna Pediatric Medical Center, Vienna, Austria.
Lena StraßmayrFirst Vienna Pediatric Medical Center, Vienna, Austria.
Peter VoitlFirst Vienna Pediatric Medical Center, Vienna, Austria.
Paulina EhlmaierFirst Vienna Pediatric Medical Center, Vienna, Austria.
Julian J M VoitlFirst Vienna Pediatric Medical Center, Vienna, Austria.
Klara LangerFirst Vienna Pediatric Medical Center, Vienna, Austria.
Ulrike KuzioFirst Vienna Pediatric Medical Center, Vienna, Austria.
Alexandra Mühl-RieglerVienna Medical Innovation Center, Vienna, Austria.
Bernhard MühlVienna Medical Innovation Center, Vienna, Austria.
Susanne C Diesner-TreiberFirst Vienna Pediatric Medical Center, Vienna, Austria.
Sigmund Freud Privatuniversität Wien · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The non-pharmaceutical measures in the first Covid-19 winter season significantly impacted respiratory pathogens such as RSV, influenza, or metapneumovirus, which cause respiratory infections, especially in infants and young children. This longitudinal prospective study aimed to determine how less strict measures affect the pathogen profile in the second winter season. Methods: From September 2021 till the end of March 2022, 678 children (0-36 months) admitted to Vienna's largest pediatric center with an acute respiratory infection were enrolled in this study. The researchers performed nasal swabs and tested them by multiplex PCR for 23 respiratory pathogens, chronicled clinical features and treatment, and analyzed the effect of lockdown on the pathogen prevalence. Results: The 815 smears of 678 children revealed the most common pathogens to be rhino-/enterovirus (38.5%), RSV (26.7%), and metapneumovirus (7.2%). The lockdown interrupted the early RSV onset in September [RR 0.367, CI (0.184-0.767), Conclusion: With more flexible non-pharmaceutical measures, children aged 0-36 months started presenting again with viral pathogens, such as RSV and metapneumovirus. RSV, associated with a high hospitalization rate, had a very early onset with an abrupt interruption due to the only lockdown.

Indexed as

acute respiratory infectionchildrenCOVID-19metapneumovirusnon-pharmaceutical measuresRSV

Identifiers

PMID36816380
PMCPMC9929140
OpenAlexW4318829732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.